Raymond James & Associates Volitionrx LTD Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
26Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$6.39 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$4.33 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA730KShares$518,6180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$452,0330.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$366,4110.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $40.7M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...